inhibitor < inhibitors < inhibitory

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by inhibitors

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000015 (2020)	Bendikt Kramer [Allemagne] ; Angela Schell [Allemagne] ; Christoph Aderhold [Allemagne] ; Lena Huber [Allemagne] ; C Emika Mueller [Allemagne] ; Nicole Rotter [Allemagne] ; Richard Birk [Allemagne]	Tyrosine Kinase Inhibitors and Everolimus Reduce IGF1R Expression in HPV16-positive and -negative Squamous Cell Carcinoma.
000046 (2020)	Jennifer Alvarez Orellana [États-Unis] ; Hyun Jin Kwun [États-Unis] ; Sara Artusi [États-Unis] ; Yuan Chang [États-Unis] ; Patrick S. Moore [États-Unis]	Sirolimus and other mTOR inhibitors directly activate latent pathogenic human polyomavirus replication.
000121 (2020)	Lena Huber [Allemagne] ; Richard Birk [Allemagne] ; Manuel Knuettel [Allemagne] ; Nicole Rotter [Allemagne] ; Christoph Aderhold [Allemagne] ; Claudia Scherl [Allemagne] ; Anne Lammert [Allemagne] ; Frederic Jungbauer [Allemagne] ; Benedikt Kramer [Allemagne]	FGF Expression in HPV16-positive and -negative SCC After Treatment With Small-molecule Tyrosine Kinase Inhibitors and Everolimus.
000149 (2020)	Richard Birk [Allemagne] ; Angela Schell [Allemagne] ; Christoph Aderhold [Allemagne] ; Stephan Hoch [Allemagne] ; Lena Huber [Allemagne] ; Cornelia Emika Mueller [Allemagne] ; Anne Lammert [Allemagne] ; Claudia Scherl [Allemagne] ; Nicole Rotter [Allemagne] ; J Ulrich Sommer [Allemagne] ; Benedikt Kramer [Allemagne]	Apoptosis-related Proteins Are Altered by Selective Tyrosine Kinase Inhibitors and Everolimus in HPV-dependent SCC.
000176 (2019)	Maryam Ghadimi [Iran] ; Zinat Mohammadpour [Iran] ; Simin Dashti-Khavidaki [Iran] ; Alireza Milajerdi [Iran]	m-TOR inhibitors and risk of Pneumocystis pneumonia after solid organ transplantation: a systematic review and meta-analysis.
000244 (2019)	Ya Yu Chernoryzh [Russie] ; N E Fedorova [Russie] ; K I Yurlov [Russie] ; R A Simonov [Russie] ; A B Kornev [Russie] ; D S Karpov [Russie] ; N F Zakirova [Russie] ; A V Ivanov [Russie] ; A A Kushch [Russie] ; A L Gintsburg [Russie]	Resistance of THP-1 Leukemia Cells Infected with Cytomegalovirus to Anti-tumor Antibiotic Doxorubicin and Restoration of the Sensitivity by Inhibitors of the PI3K/AKT/mTOR Molecular Pathway.
000334 (2019)	Ran Marciano [Israël] ; Manu Prasad [Israël] ; Tal Ievy [Israël] ; Sapir Tzadok [Israël] ; Gabriel Leprivier [Allemagne] ; Moshe Elkabets [Israël] ; Barak Rotblat [Israël]	High-Throughput Screening Identified Compounds Sensitizing Tumor Cells to Glucose Starvation in Culture and VEGF Inhibitors In Vivo.
000371 (2019)	Marina Stamenkovic [Serbie] ; Kristina Janjetovic [Serbie] ; Verica Paunovic [Serbie] ; Darko Ciric [Serbie] ; Tamara Kravic-Stevovic [Serbie] ; Vladimir Trajkovic [Serbie]	Comparative analysis of cell death mechanisms induced by lysosomal autophagy inhibitors.
000412 (2018)	N. Mazanowska [Pologne] ; M. Szpota Ska-Sikorska [Pologne] ; A. Madej [Pologne] ; J. Pazik [Pologne] ; M. Wielgo [Pologne] ; B. Pietrzak [Pologne]	Prevalence of Cervical Infection With Human Papillomavirus of High Oncogenic Potential in Immunosuppressed Women on Renal Replacement Therapy With and Without Mammalian Target of Rapamycin Inhibitors.
000414 (2018)	Larissa Sgaria Pacheco [Brésil] ; Valter Duro Garcia [Brésil] ; Ronivan Luis Dal Prá [Brésil] ; Bruna Doleys Cardoso [Brésil] ; Mariana Ferras Rodrigues [Brésil] ; Helen Kris Zanetti [Brésil] ; Gisele Meinerz [Brésil] ; Jorge Neumann [Brésil] ; Diego Gnatta [Brésil] ; Elizete Keitel [Brésil]	Effect of conversion from calcineurin inhibitors to everolimus on hepatitis C viremia in adult kidney transplant recipients.
000423 (2018)	Guoli Shi [États-Unis] ; Stosh Ozog [États-Unis] ; Bruce E. Torbett [États-Unis] ; Alex A. Compton [États-Unis]	mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3.
000433 (2018)	Laura Hulea [Canada] ; Simon-Pierre Gravel [Canada] ; Masahiro Morita [Japon] ; Marie Cargnello [France] ; Oro Uchenunu [Canada] ; Young Kyuen Im [Canada] ; Camille Lehuédé [Canada] ; Eric H. Ma [Canada] ; Matthew Leibovitch [Canada] ; Shannon Mclaughlan [Canada] ; Marie-José Blouin [Canada] ; Maxime Parisotto [Canada] ; Vasilios Papavasiliou [Canada] ; Cynthia Lavoie [Canada] ; Ola Larsson [Suède] ; Michael Ohh [Canada] ; Tiago Ferreira [Canada] ; Celia Greenwood [Canada] ; Gaëlle Bridon [Canada] ; Daina Avizonis [Canada] ; Gerardo Ferbeyre [Canada] ; Peter Siegel [Canada] ; Russell G. Jones [Canada] ; William Muller [Canada] ; Josie Ursini-Siegel [Canada] ; Julie St-Pierre [Canada] ; Michael Pollak [Canada] ; Ivan Topisirovic [Canada]	Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides.
000440 (2018)	Arash Soltani [Iran] ; Amirhossein Bahreyni [Iran] ; Nadia Boroumand [Iran] ; Mostafa Karimi Roshan [Iran] ; Majid Khazaei [Iran] ; Mikhail Ryzhikov [États-Unis] ; Saman Soleimanpour [Iran] ; Amir Avan [Iran] ; Seyed Mahdi Hassanian [Iran]	Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives.
000441 (2018)	Fatemeh Khadir [Iran, Canada] ; Christopher R. Shaler [Canada] ; Ahmad Oryan [Iran] ; Patrick T. Rudak [Canada] ; Delfina M. Mazzuca [Canada] ; Tahereh Taheri [Iran] ; Jimmy D. Dikeakos [Canada] ; S M Mansour Haeryfar [Canada] ; Sima Rafati [Iran]	Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin.
000521 (2018)	Lorena Castillo-Eraso [Espagne] ; Edoardo Melilli ; Carmen Cabre ; Anna Manonelles ; Julieta Landeyro ; Oriol Bestard ; Josep M. Cruzado ; Alberto Martinez-Vea	Posttransplant Lymphoproliferative Disease and Inhibitors of Mammalian Target of Rapamycin: When a Quick Look Back Can Change the Perspective.
000576 (2018)	Grant R. Campbell [États-Unis] ; Rachel S. Bruckman [États-Unis] ; Shayna D. Herns [États-Unis] ; Shweta Joshi [États-Unis] ; Donald L. Durden [États-Unis] ; Stephen A. Spector [États-Unis]	Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication.
000665 (2018)	Chadi Zakaria [Canada] ; Polen Sean [Canada] ; Huy-Dung Hoang [Canada] ; Louis-Phillipe Leroux [Canada] ; Margaret Watson [Canada] ; Samuel Tekeste Workenhe [Canada] ; Jaclyn Hearnden [Canada] ; Dana Pearl [Canada] ; Vinh Tai Truong [Canada] ; Nathaniel Robichaud [Canada] ; Akiko Yanagiya [Canada] ; Soroush Tahmasebi [Canada] ; Seyed Mehdi Jafarnejad [Canada] ; Jian-Jun Jia [Canada] ; Adrian Pelin [Canada] ; Jean-Simon Diallo [Canada] ; Fabrice Le Boeuf [Canada] ; John Cameron Bell [Canada] ; Karen Louise Mossman [Canada] ; Tyson Ernst Graber [Canada] ; Maritza Jaramillo [Canada] ; Nahum Sonenberg [Canada] ; Tommy Alain [Canada]	Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis.
000673 (2018)	Wakana Saso [Japon] ; Senko Tsukuda [Japon] ; Hirofumi Ohashi [Japon] ; Kento Fukano [Japon] ; Ryo Morishita [Japon] ; Satoko Matsunaga [Japon] ; Mio Ohki [Japon] ; Akihide Ryo [Japon] ; Sam-Yong Park [Japon] ; Ryosuke Suzuki [Japon] ; Hideki Aizaki [Japon] ; Masamichi Muramatsu [Japon] ; Camille Sureau [France] ; Takaji Wakita [Japon] ; Tetsuro Matano [Japon] ; Koichi Watashi [Japon]	A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.
000698 (2017)	Hassan Y. Ebrahim [États-Unis] ; Mohamed R. Akl [États-Unis] ; Heba E. Elsayed [États-Unis] ; Ronald A. Hill [États-Unis] ; Khalid A. El Sayed [États-Unis]	Usnic Acid Benzylidene Analogues as Potent Mechanistic Target of Rapamycin Inhibitors for the Control of Breast Malignancies.
000713 (2017)	L S D'Abronzo [États-Unis] ; S. Bose [États-Unis] ; M E Crapuchettes [États-Unis] ; R E Beggs [États-Unis] ; R L Vinall [États-Unis] ; C G Tepper [États-Unis] ; S. Siddiqui [États-Unis] ; M. Mudryj [États-Unis] ; F U Melgoza [États-Unis] ; B P Durbin-Johnson [États-Unis] ; R W Devere White [États-Unis] ; P M Ghosh [États-Unis]	The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.
000804 (2017)	Joshua M. Gammon [États-Unis] ; Emily A. Gosselin [États-Unis] ; Lisa H. Tostanoski [États-Unis] ; Yu-Chieh Chiu [États-Unis] ; Xiangbin Zeng [États-Unis] ; Qin Zeng [États-Unis] ; Christopher M. Jewell [États-Unis]	Low-dose controlled release of mTOR inhibitors maintains T cell plasticity and promotes central memory T cells.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "inhibitors" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    inhibitors
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020